29 November, 2019
In MS, the immune system damages the insulating coating on nerve cells known as myelin. The human body […]
13 November, 2019
The first ever treatment for secondary progressive MS, a form of MS that can follow on from relapsing remitting MS, has been approved in Australia.
29 October, 2019
The Federal Government has expanded the PBS listing of fingolimod (Gilenya) and natalizumab (Tysabri) to include younger people. […]
Dr Jane Desborough
Australian National University, ACT